Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116172254 | 11617225 | 4 | F | 201505 | 20160624 | 20151009 | 20160701 | EXP | IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-068594 | BRISTOL MYERS SQUIBB | 53.00 | YR | M | Y | 0.00000 | 20160701 | CN | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116172254 | 11617225 | 1 | PS | ABILIFY | ARIPIPRAZOLE | 1 | Oral | 15 MG, UNK | Y | 21729 | 15 | MG | ORODISPERSIBLE TABLET | ||||||
| 116172254 | 11617225 | 2 | SS | ABILIFY | ARIPIPRAZOLE | 1 | Oral | 30 MG, QD | Y | 21729 | 30 | MG | ORODISPERSIBLE TABLET | QD | |||||
| 116172254 | 11617225 | 3 | SS | ABILIFY MAINTENA | ARIPIPRAZOLE | 1 | Intramuscular | UNK, QMO | Y | 0 | 400 | MG | SOLUTION FOR INJECTION | /month | |||||
| 116172254 | 11617225 | 4 | C | HALDOL DECANOATE | HALOPERIDOL DECANOATE | 1 | Intramuscular | UNK | U | 0 | |||||||||
| 116172254 | 11617225 | 5 | C | HALOPERIDOL. | HALOPERIDOL | 1 | Oral | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 116172254 | 11617225 | 1 | Schizophrenia |
| 116172254 | 11617225 | 3 | Schizophrenia |
| 116172254 | 11617225 | 4 | Product used for unknown indication |
| 116172254 | 11617225 | 5 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 116172254 | 11617225 | OT |
| 116172254 | 11617225 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 116172254 | 11617225 | Aggression | |
| 116172254 | 11617225 | Agitation | |
| 116172254 | 11617225 | Delusion | |
| 116172254 | 11617225 | Drug ineffective | |
| 116172254 | 11617225 | Dysarthria | |
| 116172254 | 11617225 | Euphoric mood | |
| 116172254 | 11617225 | Hallucination | |
| 116172254 | 11617225 | Hospitalisation | |
| 116172254 | 11617225 | Off label use | |
| 116172254 | 11617225 | Thinking abnormal |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 116172254 | 11617225 | 1 | 20150401 | 0 | ||
| 116172254 | 11617225 | 2 | 20150422 | 0 | ||
| 116172254 | 11617225 | 3 | 20150504 | 201507 | 0 | |
| 116172254 | 11617225 | 4 | 20150407 | 0 |